Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Blamire

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Neurology|November 9, 2023
A prospective study of MRI biomarkers in the brain and lower limb muscles for prediction of lower limb motor recovery following strokeMat Elameer, Hannah Lumley, Sarah A Moore, et al.
Frontiers in Aging Neuroscience|December 7, 2018
Structural Brain Correlates of Attention Dysfunction in Lewy Body Dementias and Alzheimer's DiseaseRuth A Cromarty, Julia Schumacher, Sara Graziadio, et al.
The Lancet. Psychiatry|April 1, 2017
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trialIan M Anderson, Andrew Blamire, Tim Branton, et al.
BMC Psychiatry|October 23, 2015
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)Liam Trevithick, R Hamish McAllister-Williams, Andrew Blamire, et al.
Neuromodulation : Journal of the International Neuromodulation Society|April 10, 2023
The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's SyndromeJessica Tarn, Evelyn Evans, Emmanuella Traianos, et al.
BMJ Open|July 10, 2020
Connectivity guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment-resistant moderate to severe depression: study protocol for a randomised double-blind controlled trial (BRIGhTMIND)Richard Morriss, Lucy Webster, Mohamed Abdelghani, et al.
JMIR Research Protocols|January 20, 2022
Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2-Induced Changes for a Randomized Double-blind Controlled TrialStefan Pszczolkowski, William J Cottam, Paul M Briley, et al.
Brain Communications|December 5, 2025
Elevated glioma-related cortical glutamate <i>in vivo</i> is associated with <i>ex vivo</i> interictal discharges in human brain slicesBodiabaduge Ashan P Jayasekera, Jehill Parikh, Tamara Modebadze, et al.
Journal of Neurology|May 26, 2026
Identification of prognostic biomarkers in a large cohort of patients with LGMD R2Carla F Bolano-Diaz, Jose Verdu-Diaz, Dan Hao, et al.
Neuromuscular Disorders : NMD|January 23, 2023
Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathyUrsula Moore, Esther Fernández-Simón, Marianela Schiava, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Neurology|November 9, 2023
A prospective study of MRI biomarkers in the brain and lower limb muscles for prediction of lower limb motor recovery following strokeMat Elameer, Hannah Lumley, Sarah A Moore, et al.
Frontiers in Aging Neuroscience|December 7, 2018
Structural Brain Correlates of Attention Dysfunction in Lewy Body Dementias and Alzheimer's DiseaseRuth A Cromarty, Julia Schumacher, Sara Graziadio, et al.
The Lancet. Psychiatry|April 1, 2017
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trialIan M Anderson, Andrew Blamire, Tim Branton, et al.
BMC Psychiatry|October 23, 2015
Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study)Liam Trevithick, R Hamish McAllister-Williams, Andrew Blamire, et al.
Neuromodulation : Journal of the International Neuromodulation Society|April 10, 2023
The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's SyndromeJessica Tarn, Evelyn Evans, Emmanuella Traianos, et al.
BMJ Open|July 10, 2020
Connectivity guided theta burst transcranial magnetic stimulation versus repetitive transcranial magnetic stimulation for treatment-resistant moderate to severe depression: study protocol for a randomised double-blind controlled trial (BRIGhTMIND)Richard Morriss, Lucy Webster, Mohamed Abdelghani, et al.
JMIR Research Protocols|January 20, 2022
Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2-Induced Changes for a Randomized Double-blind Controlled TrialStefan Pszczolkowski, William J Cottam, Paul M Briley, et al.
Brain Communications|December 5, 2025
Elevated glioma-related cortical glutamate <i>in vivo</i> is associated with <i>ex vivo</i> interictal discharges in human brain slicesBodiabaduge Ashan P Jayasekera, Jehill Parikh, Tamara Modebadze, et al.
Journal of Neurology|May 26, 2026
Identification of prognostic biomarkers in a large cohort of patients with LGMD R2Carla F Bolano-Diaz, Jose Verdu-Diaz, Dan Hao, et al.
Neuromuscular Disorders : NMD|January 23, 2023
Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathyUrsula Moore, Esther Fernández-Simón, Marianela Schiava, et al.
Pageof 4